Global Cord Blood (NYSE:CO) Shares Cross Above 200 Day Moving Average - Should You Sell?

Key Points

• Global Cord Blood's share price has crossed above its 200-day moving average of $0.99, reaching a high of $1.05 during trading.
• Wall Street Zen has initiated coverage and set a "strong-buy" rating for Global Cord Blood, indicating positive outlook for the company's stock.
• The company currently has a market cap of $127.63 million and a price-to-earnings ratio of 1.64, though its stock is down 40.0% overall.

Global Cord Blood Co. (NYSE:CO - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.99 and traded as high as $1.05. Global Cord Blood shares last traded at $1.05, with a volume of 11,455 shares trading hands.

Analysts Set New Price Targets

Separately, Wall Street Zen assumed coverage on shares of Global Cord Blood in a research report on Saturday, May 17th. They set a "strong-buy" rating on the stock.

Global Cord Blood Stock Performance

The stock has a market capitalization of $127.63 million, a P/E ratio of 1.64 and a beta of 0.16. The firm's fifty day moving average is $1.03 and its 200-day moving average is $0.99.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.